Show notes
Weight loss drugs like GLP-1s have exposed a deep divide in how employers think about preventative health care, and who gets to decide what counts as medically necessary versus elective. John Baldino and Jackye Clayton dig into the real cost of prevention, from insurance denials and weight bias to what happens when companies opt out of covering it altogether.
Key Takeaways:
GLP-1 medications sit in a gray area between elective and medically necessary care, and insurers are still deciding where that line falls
Employers on level-funded or self-insured plans can see utilization data, which…

